Startups
Phosplatin Therapeutics is a private, clinical stage biopharmaceutical company founded in 2010, and funded by private investors and family investment offices in the U.S., Europe and Asia. It holds the exclusive, global license to phosphaplatins, a family of novel agents currently in clinical development for the treatment of both solid tumors and hematological cancers. Phosphaplatins are the result of over 20 years of work by the inventor, and uniquely combine an immunological form of apoptosis with an attractive safety profile. The lead agent is the subject of two approved IND applications with the US FDA, and of a collaboration and option agreement for rights in Greater China with SciClone Pharmaceuticals.
Website: www.phosplatin.com
Website: www.phosplatin.com
Overview
Location
United States, New York
Employees
11-50
Phone
+1 646-380-2441
Total raised
$55.4M
Founded date
2010
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Aug 27, 2020 | Funding round | $18.4M |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 27, 2020 | Phosplatin Therapeutics Closes $18.4M Financing Round | Phosplatin Therapeutics LLC, a NYC-based clinical stage pharmaceutical company focused on oncology therapeutics, raised $18.4m in private financing round. Participation included new and existing investors, inclusive of family offices from t... |
| Aug 26, 2020 | Phosplatin Therapeutics Completes $18.4 Million Private Financing Round | Phosplatin Therapeutics LLC, a clinical stage pharmaceutical company focused on oncology therapeutics, today announced the completion of an oversubscribed $18.4 million private financing round. Participation included new and existing invest... |
| Aug 26, 2020 | Phosplatin Therapeutics Completes $18.4 Million Private Financing Round |
Reviews 0
FAQ about Phosplatin Therapeutics
When was Phosplatin Therapeutics founded?
Phosplatin Therapeutics was founded in 2010.
How much funding has Phosplatin Therapeutics raised?
Phosplatin Therapeutics has raised $55.4M in total across 2 funding rounds.
What funding rounds has Phosplatin Therapeutics raised?
Parsers VC lists 2 funding rounds of Phosplatin Therapeutics, among them a funding round of $18.4M on Aug 27, 2020.
What has the press written about Phosplatin Therapeutics?
Parsers VC has collected 4 articles mentioning Phosplatin Therapeutics, among them “Phosplatin Therapeutics Closes $18.4M Financing Round” (Aug 27, 2020) and “Phosplatin Therapeutics Completes $18.4 Million Private Financing Round” (Aug 26, 2020).
Is Phosplatin Therapeutics still active?
Yes, Phosplatin Therapeutics is active; its latest activity on Parsers VC dates from Nov 19, 2020.